NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellens Inc.

Cellens Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://cellensinc.com/

Last Round

Seed

Dec 23, 2025

Total Funding Raised

$6.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellens Inc. is a healthcare company that develops a cell surface scanning platform designed for noninvasive detection of bladder cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

cancer diagnosticsbladder cancer testnon-invasive diagnosticsliquid biopsybladder cancer surveillanceAI diagnosticsmechanobiologyatomic force microscopyAFMcancer recurrence monitoringurology diagnosticsbiophysical biomarkersrule-out testdiagnostics-as-a-serviceCLIA-certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellens Inc. Comps

Public and private peers based on sector, stage, and business model.

Cellens Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellens Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 23, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Phuong Jean Pham

Co-Founder & CEO

Founding Team

Cellens Inc. Investors

Notable investors and investment history

Cellens Inc. investors
InvestorRounds
CANCER FUNDSeed
BrightEdgeSeed
Tufts UniversitySeed
TiE Boston AngelsSeed
Blackwood Healthcare BreakthroughsSeed
SOSVSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Grew 36% QoQ from 11 to 15 employees.

  • Dec 23, 2025

    $6.5M round led by SOSV.

View all signals

Cellens Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellens Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellens Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range17
Year Founded2020
Last FundingDec 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.